Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/24306
Title: Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes.
Authors: 
Keywords: 
Issue Date: 2016
Citation: F1000Res.2016;(5):2666
Abstract: Clonal mast cell activation syndromes and indolent systemic mastocytosis without skin involvement are two emerging entities that sometimes might be clinically difficult to distinguish, and they involve a great challenge for the physician from both a diagnostic and a therapeutic point of view. Furthermore, final diagnosis of both entities requires a bone marrow study; it is recommended that this be done in reference centers. In this article, we address the current consensus and guidelines for the suspicion, diagnosis, classification, treatment, and management of these two entities.
PMID: 27909577
URI: https://hdl.handle.net/20.500.12530/24306
Rights: openAccess
ISSN: 2046-1402
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos

Files in This Item:
File Description SizeFormat 
PMC5112577.pdf1.08 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.